Exploring New Approaches for Human Cytomegalovirus Inhibition

Dear Colleagues,

Human cytomegalovirus (HCMV) is a pervasive viral pathogen that poses significant health risks, particularly in immunocompromised individuals and neonates. Despite substantial progress in understanding HCMV biology and the development of antiviral therapies, challenges remain in effectively inhibiting HCMV infection, identyfying and managing drug resistance, and minimizing associated clinical complications. This Special Issue aims to explore new approaches for HCMV inhibition, presenting cutting-edge research and innovative strategies that hold promise in combatting this complex viral infection.

This Special Issue invites the submission of original research articles, reviews, and perspectives that encompass diverse aspects of HCMV inhibition, including, but not limited to:

• Novel targets and mechanisms for inhibiting HCMV replication;
• Development and evaluation of antiviral compounds and therapeutic agents against HCMV;
• Combinatorial approaches and drug-repurposing strategies for HCMV inhibition;
• Immunotherapeutic interventions and vaccine development for HCMV control;
• Advancements in diagnostic methods and the monitoring of HCMV infection;
• Insights into the mechanisms of HCMV drug resistance and management strategies;
• Computational modeling and drug design approaches for HCMV inhibition;
• Emerging technologies and platforms for the study of HCMV–host interactions.

We aim to foster collaboration, inspire new ideas, and advance our understanding of HCMV inhibition. We encourage researchers to submit their original work to this Special Issue, contributing to the development of effective therapeutic interventions, diagnostic tools, and preventive measures against HCMV.

Dr. Ravit Arav-Boger
Dr. Ayan Kumar Ghosh
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• human cytomegalovirus
• antiviral
• drug resistance